Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients

NCT03127020 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PIQUR Therapeutics AG

Collaborators